APA (7th ed.) Citation

Chong, S. J. F., Lu, J., Valentin, R., Lehmberg, T. Z., Eu, J. Q., Wang, J., . . . Davids, M. S. (2025). BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia. Molecular cancer, 24, . https://doi.org/10.1186/s12943-025-02260-7

Chicago Style (17th ed.) Citation

Chong, Stephen Jun Fei, et al. "BCL-2 Dependence Is a Favorable Predictive Marker of Response to Therapy for Chronic Lymphocytic Leukemia." Molecular Cancer 24 (2025). https://doi.org/10.1186/s12943-025-02260-7.

MLA (9th ed.) Citation

Chong, Stephen Jun Fei, et al. "BCL-2 Dependence Is a Favorable Predictive Marker of Response to Therapy for Chronic Lymphocytic Leukemia." Molecular Cancer, vol. 24, 2025, https://doi.org/10.1186/s12943-025-02260-7.